Clinical trial

Reducing Mortality in Adults With Advanced HIV Disease (REVIVE)

NCT05580666

StatusRECRUITING

Study typeINTERVENTIONAL

Start date2023-05-08

PhasePHASE3

Study timeline

Study start (actual)2023-05-08Date precision: day

Registry last updated2025-09-03

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

HIV Disease Progressionunresolved

Interventions

Azithromycin Oral TabletDRUG · verified · RxNorm: azithromycin Oral Tablet

Placebo oral tabletDRUG

Sponsors & collaborators

Population Health Research Institutelead sponsor

Mapped research locations

Cape TownSouth Africa4 PretoriaSouth Africa1 JohannesburgSouth Africa1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT05580666 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.